In luminal breast cancer, the existence of intratumoral CAFs exhibiting a substantial upregulation of α-SMA expression (13% within the luminal breast cancer group) demonstrated a statistically significant association with poor prognosis (p=0.019) (60). The gene discussed is ACTA1; the disease is breast carcinoma.